이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

LG Chem 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

H.C. Shin

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	5.5yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	2.5yrs

최근 관리 업데이트

Recent updates

The LG Chem (KRX:051910) Share Price Has Gained 205%, So Why Not Pay It Some Attention?

Mar 19

Are LG Chem, Ltd.'s (KRX:051910) Mixed Financials Driving The Negative Sentiment?

Mar 01

What Is The Ownership Structure Like For LG Chem, Ltd. (KRX:051910)?

Feb 08

Are LG Chem's (KRX:051910) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 04

The LG Chem (KRX:051910) Share Price Is Up 169% And Shareholders Are Boasting About It

Dec 17

Is Now The Time To Look At Buying LG Chem, Ltd. (KRX:051910)?

Nov 29

CEO

H.C. Shin (67 yo)

5.5yrs

테뉴어

Mr. Hak-Cheol Shin, also known as H.C., serves as Chairman of the Board for LG Chem, Ltd. since March 23, 2022. He serves Chief Executive Officer of LG Chem, Ltd.since March 15, 2019 and served as its Vic...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Hak-Cheol Shin	CEO & Chairman of the Board	5.5yrs	데이터 없음	데이터 없음
Dong Seok Cha	President	4.5yrs	데이터 없음	데이터 없음
Young-Moo Lee	Independent Outside Director	no data	데이터 없음	데이터 없음
WhaSun Jho	Independent Outside Director	2.5yrs	데이터 없음	데이터 없음
Hyunjoo Lee	Independent Outside Director	2.5yrs	데이터 없음	데이터 없음
Bong Seok Kwon	Non-Standing Director	2.5yrs	데이터 없음	데이터 없음
Kyung-Hoon Chun	Independent Outside Director	1.5yrs	데이터 없음	데이터 없음
Lee Young-Han	Independent Outside Director	less than a year	데이터 없음	데이터 없음

2.5yrs

평균 재임 기간

59.5yo

평균 연령

경험이 풍부한 이사회: A051910 의 이사회는 경험(평균 재직 기간 2.3 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

LG Chem 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

High number of new directors

LG Chem, Ltd., Annual General Meeting, Mar 25, 2024

LG Chem, Ltd., Annual General Meeting, Mar 25, 2021

Recent updates

New minor risk - Earnings quality

Getting In Cheap On LG Chem, Ltd. (KRX:051910) Might Be Difficult

LG Chem Adds Eco-Friendliness to Flame-Retardant Plastics

Price target decreased by 7.5% to ₩508,467

Does LG Chem (KRX:051910) Have A Healthy Balance Sheet?

LG Chem Company and AVEO Oncology Announce LG Chem's First Proprietary Anti-Cancer Compound Enters Phase 1 Clinical Study, Dosing Initiated in the U.S

Capital Allocation Trends At LG Chem (KRX:051910) Aren't Ideal

LG Chem's (KRX:051910) Soft Earnings Are Actually Better Than They Appear

High number of new directors

Why Investors Shouldn't Be Surprised By LG Chem, Ltd.'s (KRX:051910) P/E

Why LG Chem, Ltd. (KRX:051910) Could Be Worth Watching

We Think LG Chem (KRX:051910) Is Taking Some Risk With Its Debt

Full year 2023 earnings: EPS and revenues miss analyst expectations

LG Chem, Ltd., Annual General Meeting, Mar 25, 2024

Consensus EPS estimates fall by 18%

Upcoming dividend of ₩10,000 per share at 2.0% yield

Investor sentiment improves as stock rises 17%

Price target decreased by 7.2% to ₩775,500

LG Chem and LX Hausys Develop Material Delays Battery Thermal Runaway Even At 1,500°C for 20 Minutes

Second quarter 2023 earnings released: EPS: ₩6,736 (vs ₩8,452 in 2Q 2022)

Consensus EPS estimates fall by 11%

LG Chem, Ltd. announced that it expects to receive KRW 1295 billion in funding

LG Chem Considering Ways to Lift Competitiveness of Petrochemical Business

First quarter 2023 earnings released: EPS: ₩6,059 (vs ₩8,838 in 1Q 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

LG Chem, Ltd. (KOSE:A051910) completed the acquisition of AVEO Pharmaceuticals, Inc. (NasdaqCM:AVEO) from a group of shareholders.

Upcoming dividend of ₩12,000 per share

Third quarter 2022 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

LG Chem, Ltd. (KOSE:A051910) entered into a definitive agreement to acquire AVEO Pharmaceuticals, Inc. (NasdaqCM:AVEO) for approximately $520 million.

Now 23% undervalued

Now 22% undervalued

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

LG Chem Submits an IND Application to the US FDA for Its First Independent Global Phase 3 Clinical Trial of Its New Gout Drug Tigulixostat

First quarter 2022 earnings: Revenues exceed analyst expectations

LG Chem, Ltd. Develops Advanced Plastic Product to Prevent Thermal Runaway in EV Batteries

Investor sentiment improved over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Price target decreased to ₩956,800

Consensus EPS estimates fall by 11%

Now 22% undervalued after recent price drop

Now 25% undervalued after recent price drop

Upcoming dividend of ₩10,000 per share

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS ₩19,111 (vs ₩4,619 in 2Q 2020)

Consensus EPS estimates increase to ₩54,881

LG Chem Announces Topline Results of LC350189 From the Phase 2 Study (CLUE Study) Promising to Be a New Treatment Alternative With Improved Efficacy and Safety Profiles for Chronic Gout Patients

First quarter 2021 earnings released: EPS ₩12,560 (vs ₩449 in 1Q 2020)

At ₩920,000, Is It Time To Put LG Chem, Ltd. (KRX:051910) On Your Watch List?

Is LG Chem (KRX:051910) A Risky Investment?

Is LG Chem, Ltd. (KRX:051910) At Risk Of Cutting Its Dividend?

The LG Chem (KRX:051910) Share Price Has Gained 205%, So Why Not Pay It Some Attention?

LG Chem, Ltd., Annual General Meeting, Mar 25, 2021

Are LG Chem, Ltd.'s (KRX:051910) Mixed Financials Driving The Negative Sentiment?

Price target raised to ₩1,183,345

What Is The Ownership Structure Like For LG Chem, Ltd. (KRX:051910)?

New 90-day high: ₩1,028,000

Price target raised to ₩1,082,655

Price target raised to ₩1,007,828

Are LG Chem's (KRX:051910) Statutory Earnings A Good Reflection Of Its Earnings Potential?

New 90-day high: ₩889,000

The LG Chem (KRX:051910) Share Price Is Up 169% And Shareholders Are Boasting About It

Is Now The Time To Look At Buying LG Chem, Ltd. (KRX:051910)?

New 90-day high: ₩799,000

Third quarter 2020 earnings released: EPS ₩6,041

Tesla Reportedly Looks to Buy Stake in LG Energy Solution

LG Chem, Ltd. (KOSE:A051910) completed the acquisition of Ugimag Korea Co., Ltd. for KRW 23 billion.

Price target raised to ₩774,533

New 90-day high - ₩762,000

Price target raised to ₩611,733

CEO

테뉴어